World’s leading provider of genomic-based diagnostic tests that help optimize cancer care through @OncotypeIQ

Redwood City, CA
Joined September 2009
A respected physician and researcher, Joseph Sparano, MD, with @EinsteinMed, led the practice‐changing TAILORx clinical trial for #breastcancer treatment and is working to close #disparities in cancer care. ow.ly/ubPO30pU8FF
Genomic Health® retweeted
ICYMI: We expanded our cancer diagnostics capabilities through our integration with @GenomicHealth. More here: exas.co/357JZxU
6
17
Genomic Health® retweeted
Hear why Sharsheret's Director of Community Engagement Melissa Kohn Rosen is grateful for the advances in genomic testing. Learn more about Genomic Health at nomattermyage.org . #nomattermyage
Kicking off November w/ annual @bayareacancer conference. Glad to hear @l_schapira of @StanfordMed differentiate btwn side effects & long term health consequences of cancer treatment. Regardless of stage, cancer is not ever "won and done." #bcsm #bccww #CancerResearch
2
5
Genomic Health® retweeted
Every #breastcancer patient deserves personalized treatment #NoMatterMyAge. Learn more about your options at NoMatterMyAge.org
2
2
Attending @MAoftheAUA meeting next week? Meet the @GenomicHealth team in the exhibit hall to learn more about #Oncotype DX Genomic Prostate Score® assay. bit.ly/2MxDA9U #MAAUA #prostatecancer
1
2
Genomic Health® retweeted
@CCRTIreland @ProfJohnCrown want to thank our gold sponsors @Pfizer_Ireland @EisaiUS @bmsnews @GenomicHealth @Boehringer for sponsoring #TransOncXII @HerbertPark Your support is greatly appreciated as always. #cancerresearch @nicb_dcu @DcuBiotech @DCUFSH
3
5
Genomic Health® retweeted
New findings support the use of the 21-gene RS assay to guide the use of adjuvant chemotherapy in patients with hormone receptor–positive, ERBB2-negative, axillary node-negative #breastcancer ja.ma/2lIAeoR #ESMO19
9
1
16
Latest results from TAILORx, the largest ever #breastcancer treatment trial. Bob Gray, PhD, is lead statistician for TAILORx, which continues to define new standards in early breast cancer. @eaonc #ESMO19
New findings support the use of the 21-gene RS assay to guide the use of adjuvant chemotherapy in patients with hormone receptor–positive, ERBB2-negative, axillary node-negative #breastcancer ja.ma/2lIAeoR #ESMO19
7
1
10
Toll, dass der G-BA-Beschluss zu @OncotypeIQ schnell in Kraft getreten ist und Frauen mit #Brustkrebs den Test nun von der GKV gezahlt bekommen. Warum wir uns so stark für den #Oncotype eingesetzt haben, dazu nochmal unser Interview mit @chbernards: sbk.org/unsere-themen/versor…
6
7
#cap19ORL - Learn how the #Oncotype IQ Genomic Intelligence Platform provides actionable #genomic intelligence to inform #cancertreatment decisions across your patient journey at @GenomicHealth's booth bit.ly/34ngEjk
3
3
We have a winner! Here's our new 2019 Grow & Give T-Shirt! When you raise $250 through ZERO's Grow & Give (G&G) Campaign, you'll receive one of these awesome t-shirts! Sign up now to join the G&G movement: bit.ly/2EsfWpS #EndProstateCancer #prostatecancer #GrowandGive
4
6
Attending #cap10ORL next week and have questions about the @GenomicHealth DX suite? Swing by booth 411 to explore the science and talk to our team bit.ly/2QdOwwi cc: @Pathologists #urology #onocolgy
1
1
#BreastHealth launches today at ow.ly/P3gl50w2tt7 and distributed in the @guardian - featuring Dr Sophie McGrath from @GenomicHealth speak about how genomic testing is helping women tailor their breast cancer care.
1
1
1
Genomic Health® retweeted
Not all young women have more aggressive forms of #breastcancer. Getting as much information as you can about your cancer, including a genomic test result, may help you better understand the treatment option best for you. #NoMatterMyAge NoMatterMyAge.org
1
1
Genomic Health® retweeted
TAILORx established the role of the 21-gene predictor of genetic risk in ascertaining treatment for women with hormone-receptor–positive, human epidermal growth factor receptor 2–negative #breastcancer. Learn more: nej.md/2Z1njMX #ASCO19